Ferrlecit and Bradycardia - a phase IV clinical study of FDA data

Summary:

Bradycardia is reported as a side effect among people who take Ferrlecit (sodium ferric gluconate complex), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lantus, and have Iron deficiency anaemia.

The phase IV clinical study analyzes which people have Bradycardia when taking Ferrlecit. It is created by eHealthMe based on reports of 2,367 people who have side effects when taking Ferrlecit from the FDA, and is updated regularly.

What is Ferrlecit?

Ferrlecit has active ingredients of sodium ferric gluconate complex. eHealthMe is studying from 2,376 Ferrlecit users. Check the latest studies of Ferrlecit.

What is Bradycardia?

Bradycardia (abnormally slow heart action) is found to be associated with 1,930 drugs and 3,118 conditions by eHealthMe. Check the latest studies of Bradycardia.

On Jul, 14, 2026

2,367 people reported to have side effects when taking Ferrlecit.
Among them, 47 people (1.99%) have Bradycardia.

Among these 47 people:

How long have people been on Ferrlecit when they have Bradycardia? *

What is the gender of people who have Bradycardia when taking Ferrlecit? *

female: 59.52 %
male: 40.48 %

What is the age of people who have Bradycardia when taking Ferrlecit? *

What are other drugs people take besides Ferrlecit? *

What are other side effects people have besides Bradycardia? *

Hypotension (abnormally low blood pressure): 24 people, 51.06%
Loss Of Consciousness: 8 people, 17.02%
Arrhythmias (irregular heartbeat): 8 people, 17.02%
Hyperhidrosis (abnormally increased sweating): 7 people, 14.89%
Hyperkalemia (damage to or disease of the kidney): 6 people, 12.77%
Nausea (feeling of having an urge to vomit): 6 people, 12.77%
Fainting (loss of consciousness and postural tone): 6 people, 12.77%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 6 people, 12.77%
Dyspnea (difficult or laboured breathing): 6 people, 12.77%
Abdominal Pain: 5 people, 10.64%

What are the existing conditions these people have? *

Iron Deficiency Anaemia: 12 people, 25.53%
Anaemia (lack of blood): 9 people, 19.15%
Arrhythmias (irregular heartbeat): 2 people, 4.26%
Atrial Tachycardia (rhythm disturbance that arises in the atria): 2 people, 4.26%
High Blood Pressure: 2 people, 4.26%
Gout (uric acid crystals building up in the body): 2 people, 4.26%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 4.26%
Dyspnea (difficult or laboured breathing): 2 people, 4.26%
Skin Papilloma (a general medical term for a tumour of the skin or mucous membrane with finger-like projections): 1 person, 2.13%
Chronic Renal Failure Anaemia (decreased renal synthesis of hormone): 1 person, 2.13%

* Approximation only. Some reports may have incomplete information.

Do you take Ferrlecit and have Bradycardia?

- Check whether Bradycardia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ferrlecit:

Ferrlecit (2,376 reports)

Bradycardia treatments and more:

Bradycardia (61,180 reports)

How severe was Bradycardia and when was it recovered:

Bradycardia in Ferrlecit

Expand to all the drugs that have ingredients of sodium ferric gluconate complex:

Bradycardia and drugs with ingredients of sodium ferric gluconate complex

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ferrlecit:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bradycardia:

Bradycardia (1,930 drugs)

Browse all the conditions that are associated with Bradycardia:

Bradycardia (3,118 conditions)

Related publications that referenced our studies

Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .
Oflaz MB, Kucukdurmaz Z, Guven AS, Karapinar H, Kaya A, Sancakdar E, Deveci K, Gul I, Erdem A, Cevit O, Icagasioglu FD, "Bradycardia seen in children with Crimean-Congo hemorrhagic fever", Vector-Borne and Zoonotic Diseases, 2013 Nov .
Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .
Oflaz MB, Kucukdurmaz Z, Guven AS, Karapinar H, Kaya A, Sancakdar E, Deveci K, Gul I, Erdem A, Cevit O, Icagasioglu FD, "Bradycardia seen in children with Crimean-Congo hemorrhagic fever", Vector-Borne and Zoonotic Diseases, 2013 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on sodium ferric gluconate complex (the active ingredients of Ferrlecit) and Ferrlecit (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.